Vanguard crLyme helps provide broad spectrum coverage against outer surface protein A (OspA), found in the tick, and contains
antigens from multiple types of outer surface protein C (OspC), found in the tick and dog. Indication: For vaccination of healthy
dogs 8 weeks of age or older as an aid in prevention of clinical disease and subclinical arthritis associated with Borrelia
burgdorferi. Key Benefits: The first Lyme disease vaccine for dogs to contain a recombinant OspC protein. Demonstrated efficacy in
helping prevent Lyme infection. Excellent performance in a field safety study. Thimerosal free. Covered by Companion Animal
Immunization Support Guarantee (ISG).
antigens from multiple types of outer surface protein C (OspC), found in the tick and dog. Indication: For vaccination of healthy
dogs 8 weeks of age or older as an aid in prevention of clinical disease and subclinical arthritis associated with Borrelia
burgdorferi. Key Benefits: The first Lyme disease vaccine for dogs to contain a recombinant OspC protein. Demonstrated efficacy in
helping prevent Lyme infection. Excellent performance in a field safety study. Thimerosal free. Covered by Companion Animal
Immunization Support Guarantee (ISG).
- (Loading SDS PDF) SDS Sheet